文献速递瓣膜病与结构性心脏病心力衰竭与心肌病

低风险Fontan循环青少年患者的前路展望

Path ahead for 'low risk' adolescents living with a Fontan circulation.
PubMed 文献 · Heart · 2020-11-23

本研究基于澳大利亚和新西兰Fontan登记处,分析822例≥16岁Fontan患者,按是否存在持续心律失常、血栓栓塞、 transplantation、Fontan转换、蛋白丢失性肠病、塑型性支气管炎、NYHA III/IV级和/或中重度房室瓣反流或心室功能障碍,分为低风险组和增加风险组。低风险组生存率更高,Fontan失败和心室功能障碍风险更低,但低风险TCPC患者60年模型生存预测仅49%-67%。

要点

  • 低风险Fontan患者至30年生存率高于增加风险组(APC 94% vs 82%,TCPC 96% vs 89%)。
  • 低风险组Fontan失败风险显著降低(HR 0.34,95%CI 0.23-0.49)。
  • 低风险TCPC患者60年模型生存预测为49%-67%。

核心结论

  • 过渡至成人医疗时低风险的Fontan青少年患者临床结局显著优于已存在Fontan失败风险因素者。

研究设计与样本

  • 基于澳大利亚和新西兰Fontan登记处的临床结局分析,纳入822例≥16岁患者,平均年龄26±8岁,中位随访9年。

主要发现

  • 822例中203例为心房肺动脉连接(APC),619例为全腔静脉肺动脉连接(TCPC)。
  • 30年生存率低风险组 vs 增加风险组:APC 94% vs 82%(p=0.005),TCPC 96% vs 89%(p=0.05)。
  • 低风险组Fontan失败风险HR 0.34(95%CI 0.23-0.49,p<0.001),心室功能障碍风险HR 0.46(95%CI 0.29-0.71,p=0.001)。
  • 低风险TCPC患者60年模型生存预测为49%-67%。

临床怎么用

  • 低风险状态可支持个体化长期风险估计和患者咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A high risk of morbidity and mortality is well documented in adults with a Fontan circulation. The difference in outcomes between those with and without significant morbidity at the time of transition to adult care has not been well characterised. METHODS: We analysed clinical outcomes in patients enrolled in the Australian and New Zealand Fontan Registry ≥16 years of age. Low risk (LR) Fontan patients were defined as those without history of sustained arrhythmia, thromboembolic event, transplantation, Fontan conversion, protein-losing enteropathy, plastic bronchitis, New York Heart Association class III/IV and/or moderate/severe atrioventricular valve regurgitation or ventricular dysfunction. Increased risk (IR) patients had one or more risk factor. RESULTS: Inclusion criteria were met in 822 patients; mean age 26±8 years, median follow-up from age 16 was 9 years, 203 had atriopulmonary connection (APC) and 619 had total cavopulmonary connection (TCPC). Survival at 30 years was higher in the LR versus IR; 94% versus 82% (p=0.005), 89% versus 77% (p=0.07) for APC and 96% versus 89% (p=0.05) for TCPC. LR patients experienced less Fontan failure (HR 0.34, 95% CI 0.23 to 0.49, p<0.001) and ventricular dysfunction (HR 0.46, 95% CI 0.29 to 0.71, p=0.001) compared with IR patients. For LR TCPC patients, modelled survival projections at 60 years were 49%-67%. CONCLUSIONS: Clinical outcomes for adolescents LR at transition to adult care are markedly superior to those who have established risk factors for Fontan failure, which is an important consideration when formulating individualised long-term risk estimates and counselling patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Baker DW, Dennis MR, Zannino D, et al. Path ahead for 'low risk' adolescents living with a Fontan circulation. Heart. 2020. PMID: 33229361. doi:10.1136/heartjnl-2020-317619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。